Microbiotica Ltd: Clinical Trials

3 trials sponsored by Microbiotica Ltd, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 completed, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Active not recruiting 1, Completed 1

Follow Microbiotica Ltd: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
MB310, Placebo, Vancomycin - Ulcerative Colitis
Phase 1CompletedMicrobiotica Ltd292024-09-272026-06-15
A Phase 1b Trial to Evaluate Safety of MB097 in Combination With Pembrolizumab in Melanoma Patients
MB097, Pembrolizumab, Vancomycin - Melanoma
Phase 1Active not recruitingMicrobiotica Ltd412024-08-282025-09-26
Microbiome Immunotherapy Toxicity and Response Evaluation
Nivolumab, Pembrolizumab, Ipilimumab - Melanoma, Renal Cancer
UnknownCCTU- Cancer Theme18002020-07-082023-02-16

Conditions studied

Melanoma (2)  ·  Colitis, Ulcerative (1)  ·  Kidney Neoplasms (1)  ·  Lung Neoplasms (1)

Interventions

Vancomycin (2)  ·  pembrolizumab (2)  ·  Bevacizumab (1)  ·  Ipilimumab (1)  ·  Nivolumab (1)  ·  atezolizumab (1)  ·  durvalumab (1)  ·  tremelimumab (1)

Countries

United Kingdom (3)  ·  Spain (2)  ·  Austria (1)  ·  Bulgaria (1)  ·  France (1)  ·  Italy (1)  ·  Poland (1)

Top investigators

Pippa Corrie (1)

Results publications

PMID 35073853

NIH funding

2023 (2)